Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-18-002810)

Filing Details

Accession Number:
0001209191-18-002810
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-08 20:21:06
Reporting Period:
2018-01-04
Accepted Time:
2018-01-08 20:21:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437786 Immune Design Corp. IMDZ Pharmaceutical Preparations (2834) 262007174
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1606244 V Carlos Paya C/O Immune Design Corp.
1616 Eastlake Ave. E., Suite 310
Seattle WA 98102		 President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-04 46,500 $0.00 114,560 No 4 A Direct
Common Stock Disposition 2018-01-05 7,970 $4.17 106,590 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2018-01-04 216,500 $0.00 216,500 $4.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
216,500 2028-01-04 No 4 A Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of Immune Design Corp. common stock.
  2. Restricted stock units shall vest in a series of three equal consecutive annual installments beginning on January 4, 2019, subject to the Reporting Person's continuous service through each such date.
  3. The shares were sold pursuant to a Rule 10b5-1 trading plan that was included in the Reporting Person's restricted stock unit agreements, dated January 4, 2016 and January 4, 2017, in order to satisfy a tax liability incurred upon the vesting of restricted stock units on January 4, 2018.
  4. One quarter of the shares underlying the option will vest on January 4, 2019, and the remainder of the shares underlying the option will vest at a rate of 1/24th per month thereafter, subject to the Reporting Person's continuous service through each such date.